MedTrace Logo

Clinical Trials

NCT04195451 | COMPLETED | NA
150 participants

Re-Energize Fontan

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2020-08-06
Completion:
2026-02-27
Conditions
  • Single-ventricle
Interventions
  • OTHER
No Results Yet
NCT04106466 | ACTIVE_NOT_RECRUITING | NA
10 participants

DBS for TRD With the Medtronic Summit RC+S

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2020-01-21
Completion:
2030-12-31
Conditions
  • Major Depressive Disorder
  • Treatment Resistant Depression
Interventions
  • DEVICE
No Results Yet
NCT03670966 | RECRUITING | PHASE1/PHASE2
30 participants

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2019-07-10
Completion:
2028-01-28
Conditions
  • Acute Lymphoblastic Leukemia in Remission
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Acute Myeloid Leukemia in Remission
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome With Excess Blasts
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Recurrent Mixed Phenotype Acute Leukemia
  • Refractory Mixed Phenotype Acute Leukemia
  • Hematopoietic and Lymphoid Cell Neoplasm
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT03476681 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
121 participants

Study of NEO-201 in Solid Tumors Expansion Cohorts

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2019-01-18
Completion:
2026-06-17
Conditions
  • Non Small Cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Cervical Cancer
  • Uterine Cancer
Interventions
  • DRUG
No Results Yet
NCT03301038 | RECRUITING | PHASE2
60 participants

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2018-07-25
Completion:
2027-12-31
Conditions
  • Idiopathic Infantile Hypercalcaemia - Severe Form
  • Genetic Disease
  • Hypercalcemia, Idiopathic, of Infancy
  • Hypercalciuric Hypercalcemia
  • Idiopathic Infantile Hypercalcemia - Mild Form
  • Hypercalciuria
Interventions
  • DRUG
No Results Yet
NCT03277729 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
53 participants

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2017-12-05
Completion:
2024-03-29
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Follicular Lymphoma
  • Recurrent Lymphoplasmacytic Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Lymphoplasmacytic Lymphoma
  • Refractory Mantle Cell Lymphoma
  • Refractory Transformed Non-Hodgkin Lymphoma
  • Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
  • Recurrent Transformed Chronic Lymphocytic Leukemia
  • Refractory Marginal Zone Lymphoma
  • Refractory Transformed B-Cell Non-Hodgkin Lymphoma
  • Refractory Transformed Chronic Lymphocytic Leukemia
  • Recurrent Small Lymphocytic Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Small Lymphocytic Lymphoma
  • Recurrent Central Nervous System Lymphoma
  • Refractory Central Nervous System Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
  • PROCEDURE
Results Available
NCT03128034 | RECRUITING | PHASE1/PHASE2
75 participants

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2017-10-24
Completion:
2027-06-30
Conditions
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome With Excess Blasts
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Lymphoblastic Leukemia
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Mixed Phenotype Acute Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Mixed Phenotype Acute Leukemia
  • Mixed Phenotype Acute Leukemia
Interventions
  • DRUG
  • PROCEDURE
  • RADIATION
No Results Yet
NCT03110978 | ACTIVE_NOT_RECRUITING | PHASE2
140 participants

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2017-06-26
Completion:
2028-06-30
Conditions
  • Lung Atypical Carcinoid Tumor
  • Lung Neuroendocrine Neoplasm
  • Lung Non-Small Cell Squamous Carcinoma
  • Minimally Invasive Lung Adenocarcinoma
  • Neuroendocrine Carcinoma
  • Recurrent Lung Adenocarcinoma
  • Recurrent Lung Large Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage I Lung Cancer AJCC v8
  • Stage IA1 Lung Cancer AJCC v8
  • Stage IA2 Lung Cancer AJCC v8
  • Stage IA3 Lung Cancer AJCC v8
  • Stage IB Lung Cancer AJCC v8
  • Stage IIA Lung Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT02918253 | ACTIVE_NOT_RECRUITING | NA
60 participants

HDR Focal: Feasibility Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2016-10-14
Completion:
2027-11-30
Conditions
  • Prostate Cancer
Interventions
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page